Sinsin Pharmaceutical Co., Ltd (KOSDAQ: 002800)

Sinsin Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 11, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	93,299	94,664	84,651	97,850	138,658	103,463
Market Cap Growth	12.68%	11.83%	-13.49%	-29.43%	34.02%	-6.96%
Enterprise Value	136,977	135,899	130,024	145,574	183,301	156,596
Last Close Price	6150.00	6240.00	5524.57	6328.08	8967.24	6691.09
PE Ratio	23.08	20.23	18.99	-65.04	375.11	47.49
PS Ratio	0.89	0.92	0.92	1.32	2.07	1.52
PB Ratio	1.45	1.52	1.42	1.79	2.47	1.84
P/FCF Ratio	179.47	-87.55	18.59	-36.80	-13.72	-4.14
P/OCF Ratio	23.41	24.09	15.50	4220.66	74.34	-22.96
EV/Sales Ratio	1.30	1.32	1.41	1.97	2.73	2.31
EV/EBITDA Ratio	13.43	13.67	14.16	62.51	-115.60	44.74
EV/EBIT Ratio	22.61	22.64	23.96	-108.43	-43.96	67.24
EV/FCF Ratio	263.49	-125.69	28.56	-54.75	-18.14	-6.26
Debt / Equity Ratio	0.70	0.72	0.73	0.84	0.81	0.96
Debt / EBITDA Ratio	4.38	4.48	4.73	19.85	-	15.39
Debt / FCF Ratio	86.04	-41.16	9.55	-17.39	-4.47	-2.15
Asset Turnover	0.83	0.84	0.78	0.64	0.54	0.57
Inventory Turnover	4.55	4.60	4.98	4.60	3.84	3.95
Quick Ratio	0.63	0.59	0.71	0.76	0.77	0.78
Current Ratio	0.93	0.91	1.06	1.08	1.15	1.28
Return on Equity (ROE)	6.30%	7.64%	7.62%	-2.62%	0.36%	3.65%
Return on Assets (ROA)	2.98%	3.06%	2.88%	-0.72%	-2.11%	1.23%
Return on Capital (ROIC)	3.52%	3.58%	3.32%	-0.83%	-2.46%	1.50%
Earnings Yield	4.33%	4.94%	5.21%	-1.51%	0.26%	2.07%
FCF Yield	0.56%	-1.14%	5.38%	-2.72%	-7.29%	-24.17%
Dividend Yield	0.98%	0.96%	-	-	-	0.42%
Payout Ratio	22.48%	16.21%	-	-	117.13%	23.42%
Total Shareholder Return	0.98%	0.96%	-	-	-	0.42%

Source: S&P Capital IQ. Standard template. Financial Sources.